<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258093/" ref="ordinalpos=4748&amp;ncbi_uid=6955184&amp;link_uid=PMC4258093" image-link="/pmc/articles/PMC4258093/figure/fig05/" class="imagepopup">Fig 5.  From: Signals Controlling Un-Differentiated States in Embryonic Stem and Cancer Cells: Role of the Phosphatidylinositol 3′ Kinase <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">TGF-β signaling. The pathway is activated when aTGF-β superfamily ligand binds to a TGF-β type II receptor dimer, which recruits and phosphorylates a type I receptor dimer forming a hetero-tetrameric complex with the ligand. The type I receptor goes on to phosphorylate R-Smads. Phosphorylated R-SMADs have a high affinity for the effector protein, coSMAD, and consequently forms a complex with coSMAD. R-SMAD/coSMAD complexes accumulate and enter the nucleus where they activate transcription.</div></div>